img

Global Oncology Injection Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Oncology Injection Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Oncology Injection Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Oncology Injection Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Lymphoma and Myeloma are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Oncology Injection Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Oncology Injection Drug key manufacturers include Taj Oncology, S.G. Biopharm, AdvaCare, Merrimack, Celgene, Allos Therapeutics, Ferring Pharmaceuticals, Genzyme and Eli Lilly, etc. Taj Oncology, S.G. Biopharm, AdvaCare are top 3 players and held % sales share in total in 2022.
Oncology Injection Drug can be divided into Organs, Central Nervous System, Circulatory/Musculoskeletal System and Other, etc. Organs is the mainstream product in the market, accounting for % sales share globally in 2022.
Oncology Injection Drug is widely used in various fields, such as Lymphoma, Myeloma, Prostate Cancer and Other, etc. Lymphoma provides greatest supports to the Oncology Injection Drug industry development. In 2022, global % sales of Oncology Injection Drug went into Lymphoma filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Oncology Injection Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Taj Oncology
S.G. Biopharm
AdvaCare
Merrimack
Celgene
Allos Therapeutics
Ferring Pharmaceuticals
Genzyme
Eli Lilly
Praecis Pharmaceuticals
Millennium Pharmaceuticals
Debiopharm
Alza
CordenPharma
Pharmascience
Segment by Type
Organs
Central Nervous System
Circulatory/Musculoskeletal System
Other

Segment by Application


Lymphoma
Myeloma
Prostate Cancer
Other

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Oncology Injection Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Oncology Injection Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Oncology Injection Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Oncology Injection Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Oncology Injection Drug introduction, etc. Oncology Injection Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Oncology Injection Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Oncology Injection Drug Market Overview
1.1 Oncology Injection Drug Product Overview
1.2 Oncology Injection Drug Market Segment by Type
1.2.1 Organs
1.2.2 Central Nervous System
1.2.3 Circulatory/Musculoskeletal System
1.2.4 Other
1.3 Global Oncology Injection Drug Market Size by Type
1.3.1 Global Oncology Injection Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Oncology Injection Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Oncology Injection Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Oncology Injection Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Oncology Injection Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Oncology Injection Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Oncology Injection Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Oncology Injection Drug Sales Breakdown by Type (2018-2024)
2 Global Oncology Injection Drug Market Competition by Company
2.1 Global Top Players by Oncology Injection Drug Sales (2018-2024)
2.2 Global Top Players by Oncology Injection Drug Revenue (2018-2024)
2.3 Global Top Players by Oncology Injection Drug Price (2018-2024)
2.4 Global Top Manufacturers Oncology Injection Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Oncology Injection Drug Market Competitive Situation and Trends
2.5.1 Oncology Injection Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Oncology Injection Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oncology Injection Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Oncology Injection Drug Market
2.8 Key Manufacturers Oncology Injection Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Oncology Injection Drug Status and Outlook by Region
3.1 Global Oncology Injection Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Oncology Injection Drug Historic Market Size by Region
3.2.1 Global Oncology Injection Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Oncology Injection Drug Sales in Value by Region (2018-2024)
3.2.3 Global Oncology Injection Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Oncology Injection Drug Forecasted Market Size by Region
3.3.1 Global Oncology Injection Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Oncology Injection Drug Sales in Value by Region (2024-2034)
3.3.3 Global Oncology Injection Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Oncology Injection Drug by Application
4.1 Oncology Injection Drug Market Segment by Application
4.1.1 Lymphoma
4.1.2 Myeloma
4.1.3 Prostate Cancer
4.1.4 Other
4.2 Global Oncology Injection Drug Market Size by Application
4.2.1 Global Oncology Injection Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Oncology Injection Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Oncology Injection Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Oncology Injection Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Oncology Injection Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Oncology Injection Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Oncology Injection Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Oncology Injection Drug Sales Breakdown by Application (2018-2024)
5 North America Oncology Injection Drug by Country
5.1 North America Oncology Injection Drug Historic Market Size by Country
5.1.1 North America Oncology Injection Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Oncology Injection Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Oncology Injection Drug Sales in Value by Country (2018-2024)
5.2 North America Oncology Injection Drug Forecasted Market Size by Country
5.2.1 North America Oncology Injection Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Oncology Injection Drug Sales in Value by Country (2024-2034)
6 Europe Oncology Injection Drug by Country
6.1 Europe Oncology Injection Drug Historic Market Size by Country
6.1.1 Europe Oncology Injection Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Oncology Injection Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Oncology Injection Drug Sales in Value by Country (2018-2024)
6.2 Europe Oncology Injection Drug Forecasted Market Size by Country
6.2.1 Europe Oncology Injection Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Oncology Injection Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Oncology Injection Drug by Region
7.1 Asia-Pacific Oncology Injection Drug Historic Market Size by Region
7.1.1 Asia-Pacific Oncology Injection Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Oncology Injection Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Oncology Injection Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Oncology Injection Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Oncology Injection Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Oncology Injection Drug Sales in Value by Region (2024-2034)
8 Latin America Oncology Injection Drug by Country
8.1 Latin America Oncology Injection Drug Historic Market Size by Country
8.1.1 Latin America Oncology Injection Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Oncology Injection Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Oncology Injection Drug Sales in Value by Country (2018-2024)
8.2 Latin America Oncology Injection Drug Forecasted Market Size by Country
8.2.1 Latin America Oncology Injection Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Oncology Injection Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Oncology Injection Drug by Country
9.1 Middle East and Africa Oncology Injection Drug Historic Market Size by Country
9.1.1 Middle East and Africa Oncology Injection Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Oncology Injection Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Oncology Injection Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Oncology Injection Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Oncology Injection Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Oncology Injection Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Taj Oncology
10.1.1 Taj Oncology Company Information
10.1.2 Taj Oncology Introduction and Business Overview
10.1.3 Taj Oncology Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Taj Oncology Oncology Injection Drug Products Offered
10.1.5 Taj Oncology Recent Development
10.2 S.G. Biopharm
10.2.1 S.G. Biopharm Company Information
10.2.2 S.G. Biopharm Introduction and Business Overview
10.2.3 S.G. Biopharm Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 S.G. Biopharm Oncology Injection Drug Products Offered
10.2.5 S.G. Biopharm Recent Development
10.3 AdvaCare
10.3.1 AdvaCare Company Information
10.3.2 AdvaCare Introduction and Business Overview
10.3.3 AdvaCare Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 AdvaCare Oncology Injection Drug Products Offered
10.3.5 AdvaCare Recent Development
10.4 Merrimack
10.4.1 Merrimack Company Information
10.4.2 Merrimack Introduction and Business Overview
10.4.3 Merrimack Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Merrimack Oncology Injection Drug Products Offered
10.4.5 Merrimack Recent Development
10.5 Celgene
10.5.1 Celgene Company Information
10.5.2 Celgene Introduction and Business Overview
10.5.3 Celgene Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Celgene Oncology Injection Drug Products Offered
10.5.5 Celgene Recent Development
10.6 Allos Therapeutics
10.6.1 Allos Therapeutics Company Information
10.6.2 Allos Therapeutics Introduction and Business Overview
10.6.3 Allos Therapeutics Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Allos Therapeutics Oncology Injection Drug Products Offered
10.6.5 Allos Therapeutics Recent Development
10.7 Ferring Pharmaceuticals
10.7.1 Ferring Pharmaceuticals Company Information
10.7.2 Ferring Pharmaceuticals Introduction and Business Overview
10.7.3 Ferring Pharmaceuticals Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Ferring Pharmaceuticals Oncology Injection Drug Products Offered
10.7.5 Ferring Pharmaceuticals Recent Development
10.8 Genzyme
10.8.1 Genzyme Company Information
10.8.2 Genzyme Introduction and Business Overview
10.8.3 Genzyme Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Genzyme Oncology Injection Drug Products Offered
10.8.5 Genzyme Recent Development
10.9 Eli Lilly
10.9.1 Eli Lilly Company Information
10.9.2 Eli Lilly Introduction and Business Overview
10.9.3 Eli Lilly Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Eli Lilly Oncology Injection Drug Products Offered
10.9.5 Eli Lilly Recent Development
10.10 Praecis Pharmaceuticals
10.10.1 Praecis Pharmaceuticals Company Information
10.10.2 Praecis Pharmaceuticals Introduction and Business Overview
10.10.3 Praecis Pharmaceuticals Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Praecis Pharmaceuticals Oncology Injection Drug Products Offered
10.10.5 Praecis Pharmaceuticals Recent Development
10.11 Millennium Pharmaceuticals
10.11.1 Millennium Pharmaceuticals Company Information
10.11.2 Millennium Pharmaceuticals Introduction and Business Overview
10.11.3 Millennium Pharmaceuticals Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Millennium Pharmaceuticals Oncology Injection Drug Products Offered
10.11.5 Millennium Pharmaceuticals Recent Development
10.12 Debiopharm
10.12.1 Debiopharm Company Information
10.12.2 Debiopharm Introduction and Business Overview
10.12.3 Debiopharm Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Debiopharm Oncology Injection Drug Products Offered
10.12.5 Debiopharm Recent Development
10.13 Alza
10.13.1 Alza Company Information
10.13.2 Alza Introduction and Business Overview
10.13.3 Alza Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Alza Oncology Injection Drug Products Offered
10.13.5 Alza Recent Development
10.14 CordenPharma
10.14.1 CordenPharma Company Information
10.14.2 CordenPharma Introduction and Business Overview
10.14.3 CordenPharma Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2024)
10.14.4 CordenPharma Oncology Injection Drug Products Offered
10.14.5 CordenPharma Recent Development
10.15 Pharmascience
10.15.1 Pharmascience Company Information
10.15.2 Pharmascience Introduction and Business Overview
10.15.3 Pharmascience Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Pharmascience Oncology Injection Drug Products Offered
10.15.5 Pharmascience Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Oncology Injection Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Oncology Injection Drug Industrial Chain Analysis
11.4 Oncology Injection Drug Market Dynamics
11.4.1 Oncology Injection Drug Industry Trends
11.4.2 Oncology Injection Drug Market Drivers
11.4.3 Oncology Injection Drug Market Challenges
11.4.4 Oncology Injection Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Oncology Injection Drug Distributors
12.3 Oncology Injection Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Organs
Table 2. Major Company of Central Nervous System
Table 3. Major Company of Circulatory/Musculoskeletal System
Table 4. Major Company of Other
Table 5. Global Oncology Injection Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Oncology Injection Drug Sales by Type (2018-2024) & (K Pcs)
Table 7. Global Oncology Injection Drug Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Oncology Injection Drug Sales by Type (2018-2024) & (US& Million)
Table 9. Global Oncology Injection Drug Market Share in Value by Type (2018-2024)
Table 10. Global Oncology Injection Drug Price by Type (2018-2024) & (USD/Pcs)
Table 11. Global Oncology Injection Drug Sales by Type (2024-2034) & (K Pcs)
Table 12. Global Oncology Injection Drug Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Oncology Injection Drug Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Oncology Injection Drug Sales Market Share in Value by Type (2024-2034)
Table 15. Global Oncology Injection Drug Price by Type (2024-2034) & (USD/Pcs)
Table 16. North America Oncology Injection Drug Sales by Type (2018-2024) & (K Pcs)
Table 17. North America Oncology Injection Drug Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Oncology Injection Drug Sales (K Pcs) by Type (2018-2024)
Table 19. Europe Oncology Injection Drug Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Oncology Injection Drug Sales (K Pcs) by Type (2018-2024)
Table 21. Asia-Pacific Oncology Injection Drug Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Oncology Injection Drug Sales (K Pcs) by Type (2018-2024)
Table 23. Latin America Oncology Injection Drug Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Oncology Injection Drug Sales (K Pcs) by Type (2018-2024)
Table 25. Middle East and Africa Oncology Injection Drug Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Oncology Injection Drug Sales by Company (2018-2024) & (K Pcs)
Table 27. Global Oncology Injection Drug Sales Share by Company (2018-2024)
Table 28. Global Oncology Injection Drug Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Oncology Injection Drug Revenue Share by Company (2018-2024)
Table 30. Global Market Oncology Injection Drug Price by Company (2018-2024) & (USD/Pcs)
Table 31. Global Oncology Injection Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Oncology Injection Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oncology Injection Drug as of 2022)
Table 34. Date of Key Manufacturers Enter into Oncology Injection Drug Market
Table 35. Key Manufacturers Oncology Injection Drug Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Oncology Injection Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Oncology Injection Drug Sales by Region (2018-2024) & (K Pcs)
Table 39. Global Oncology Injection Drug Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Oncology Injection Drug Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Oncology Injection Drug Sales Market Share in Value by Region (2018-2024)
Table 42. Global Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 43. Global Oncology Injection Drug Sales by Region (2024-2034) & (K Pcs)
Table 44. Global Oncology Injection Drug Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Oncology Injection Drug Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Oncology Injection Drug Sales Market Share in Value by Region (2024-2034)
Table 47. Global Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 48. Global Oncology Injection Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Oncology Injection Drug Sales by Application (2018-2024) & (K Pcs)
Table 50. Global Oncology Injection Drug Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Oncology Injection Drug Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Oncology Injection Drug Sales Market Share in Value by Application (2018-2024)
Table 53. Global Oncology Injection Drug Price by Application (2018-2024) & (USD/Pcs)
Table 54. Global Oncology Injection Drug Sales by Application (2024-2034) & (K Pcs)
Table 55. Global Oncology Injection Drug Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Oncology Injection Drug Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Oncology Injection Drug Sales Market Share in Value by Application (2024-2034)
Table 58. Global Oncology Injection Drug Price by Application (2024-2034) & (USD/Pcs)
Table 59. North America Oncology Injection Drug Sales by Application (2018-2024) (K Pcs)
Table 60. North America Oncology Injection Drug Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Oncology Injection Drug Sales by Application (2018-2024) (K Pcs)
Table 62. Europe Oncology Injection Drug Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Oncology Injection Drug Sales by Application (2018-2024) (K Pcs)
Table 64. Asia-Pacific Oncology Injection Drug Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Oncology Injection Drug Sales by Application (2018-2024) (K Pcs)
Table 66. Latin America Oncology Injection Drug Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Oncology Injection Drug Sales by Application (2018-2024) (K Pcs)
Table 68. Middle East and Africa Oncology Injection Drug Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Oncology Injection Drug Sales by Country (2018-2024) & (K Pcs)
Table 70. North America Oncology Injection Drug Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Oncology Injection Drug Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Oncology Injection Drug Sales Market Share in Value by Country (2018-2024)
Table 73. North America Oncology Injection Drug Sales by Country (2024-2034) & (K Pcs)
Table 74. North America Oncology Injection Drug Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Oncology Injection Drug Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Oncology Injection Drug Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Oncology Injection Drug Sales by Country (2018-2024) & (K Pcs)
Table 78. Europe Oncology Injection Drug Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Oncology Injection Drug Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Oncology Injection Drug Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Oncology Injection Drug Sales by Country (2024-2034) & (K Pcs)
Table 82. Europe Oncology Injection Drug Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Oncology Injection Drug Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Oncology Injection Drug Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Oncology Injection Drug Sales by Region (2018-2024) & (K Pcs)
Table 86. Asia-Pacific Oncology Injection Drug Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Oncology Injection Drug Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Oncology Injection Drug Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Oncology Injection Drug Sales by Region (2024-2034) & (K Pcs)
Table 90. Asia-Pacific Oncology Injection Drug Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Oncology Injection Drug Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Oncology Injection Drug Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Oncology Injection Drug Sales by Country (2018-2024) & (K Pcs)
Table 94. Latin America Oncology Injection Drug Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Oncology Injection Drug Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Oncology Injection Drug Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Oncology Injection Drug Sales by Country (2024-2034) & (K Pcs)
Table 98. Latin America Oncology Injection Drug Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Oncology Injection Drug Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Oncology Injection Drug Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Oncology Injection Drug Sales by Country (2018-2024) & (K Pcs)
Table 102. Middle East and Africa Oncology Injection Drug Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Oncology Injection Drug Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Oncology Injection Drug Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Oncology Injection Drug Sales by Country (2024-2034) & (K Pcs)
Table 106. Middle East and Africa Oncology Injection Drug Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Oncology Injection Drug Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Oncology Injection Drug Sales Market Share in Value by Country (2024-2034)
Table 109. Taj Oncology Company Information
Table 110. Taj Oncology Introduction and Business Overview
Table 111. Taj Oncology Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 112. Taj Oncology Oncology Injection Drug Product
Table 113. Taj Oncology Recent Development
Table 114. S.G. Biopharm Company Information
Table 115. S.G. Biopharm Introduction and Business Overview
Table 116. S.G. Biopharm Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 117. S.G. Biopharm Oncology Injection Drug Product
Table 118. S.G. Biopharm Recent Development
Table 119. AdvaCare Company Information
Table 120. AdvaCare Introduction and Business Overview
Table 121. AdvaCare Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 122. AdvaCare Oncology Injection Drug Product
Table 123. AdvaCare Recent Development
Table 124. Merrimack Company Information
Table 125. Merrimack Introduction and Business Overview
Table 126. Merrimack Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 127. Merrimack Oncology Injection Drug Product
Table 128. Merrimack Recent Development
Table 129. Celgene Company Information
Table 130. Celgene Introduction and Business Overview
Table 131. Celgene Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 132. Celgene Oncology Injection Drug Product
Table 133. Celgene Recent Development
Table 134. Allos Therapeutics Company Information
Table 135. Allos Therapeutics Introduction and Business Overview
Table 136. Allos Therapeutics Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 137. Allos Therapeutics Oncology Injection Drug Product
Table 138. Allos Therapeutics Recent Development
Table 139. Ferring Pharmaceuticals Company Information
Table 140. Ferring Pharmaceuticals Introduction and Business Overview
Table 141. Ferring Pharmaceuticals Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 142. Ferring Pharmaceuticals Oncology Injection Drug Product
Table 143. Ferring Pharmaceuticals Recent Development
Table 144. Genzyme Company Information
Table 145. Genzyme Introduction and Business Overview
Table 146. Genzyme Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 147. Genzyme Oncology Injection Drug Product
Table 148. Genzyme Recent Development
Table 149. Eli Lilly Company Information
Table 150. Eli Lilly Introduction and Business Overview
Table 151. Eli Lilly Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 152. Eli Lilly Oncology Injection Drug Product
Table 153. Eli Lilly Recent Development
Table 154. Praecis Pharmaceuticals Company Information
Table 155. Praecis Pharmaceuticals Introduction and Business Overview
Table 156. Praecis Pharmaceuticals Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 157. Praecis Pharmaceuticals Oncology Injection Drug Product
Table 158. Praecis Pharmaceuticals Recent Development
Table 159. Millennium Pharmaceuticals Company Information
Table 160. Millennium Pharmaceuticals Introduction and Business Overview
Table 161. Millennium Pharmaceuticals Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 162. Millennium Pharmaceuticals Oncology Injection Drug Product
Table 163. Millennium Pharmaceuticals Recent Development
Table 164. Debiopharm Company Information
Table 165. Debiopharm Introduction and Business Overview
Table 166. Debiopharm Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 167. Debiopharm Oncology Injection Drug Product
Table 168. Debiopharm Recent Development
Table 169. Alza Company Information
Table 170. Alza Introduction and Business Overview
Table 171. Alza Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 172. Alza Oncology Injection Drug Product
Table 173. Alza Recent Development
Table 174. CordenPharma Company Information
Table 175. CordenPharma Introduction and Business Overview
Table 176. CordenPharma Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 177. CordenPharma Oncology Injection Drug Product
Table 178. CordenPharma Recent Development
Table 179. Pharmascience Company Information
Table 180. Pharmascience Introduction and Business Overview
Table 181. Pharmascience Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 182. Pharmascience Oncology Injection Drug Product
Table 183. Pharmascience Recent Development
Table 184. Key Raw Materials Lists
Table 185. Raw Materials Key Suppliers Lists
Table 186. Oncology Injection Drug Market Trends
Table 187. Oncology Injection Drug Market Drivers
Table 188. Oncology Injection Drug Market Challenges
Table 189. Oncology Injection Drug Market Restraints
Table 190. Oncology Injection Drug Distributors List
Table 191. Oncology Injection Drug Downstream Customers
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
List of Figures
Figure 1. Oncology Injection Drug Product Picture
Figure 2. Global Oncology Injection Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Oncology Injection Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Oncology Injection Drug Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of Organs
Figure 6. Global Organs Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of Central Nervous System
Figure 8. Global Central Nervous System Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of Circulatory/Musculoskeletal System
Figure 10. Global Circulatory/Musculoskeletal System Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Other
Figure 12. Global Other Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Global Oncology Injection Drug Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Oncology Injection Drug Sales Market Share by Type in 2022 & 2034
Figure 15. North America Oncology Injection Drug Sales Market Share in Volume by Type in 2022
Figure 16. North America Oncology Injection Drug Sales Market Share in Value by Type in 2022
Figure 17. Europe Oncology Injection Drug Sales Market Share in Volume by Type in 2022
Figure 18. Europe Oncology Injection Drug Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Oncology Injection Drug Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Oncology Injection Drug Sales Market Share in Value by Type in 2022
Figure 21. Latin America Oncology Injection Drug Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Oncology Injection Drug Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Oncology Injection Drug Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Oncology Injection Drug Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Oncology Injection Drug Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Oncology Injection Drug Revenue in 2022
Figure 27. Oncology Injection Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Lymphoma
Figure 29. Global Lymphoma Sales YoY Growth (2018-2034) & (K Pcs)
Figure 30. Product Picture of Myeloma
Figure 31. Global Myeloma Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Prostate Cancer
Figure 33. Global Prostate Cancer Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Other
Figure 35. Global Other Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Global Oncology Injection Drug Sales by Application (2018-2034) & (US$ Million)
Figure 37. Global Oncology Injection Drug Sales Market Share by Application in 2022 & 2034
Figure 38. North America Oncology Injection Drug Sales Market Share in Volume by Application in 2022
Figure 39. North America Oncology Injection Drug Sales Market Share in Value by Application in 2022
Figure 40. Europe Oncology Injection Drug Sales Market Share in Volume by Application in 2022
Figure 41. Europe Oncology Injection Drug Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Oncology Injection Drug Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Oncology Injection Drug Sales Market Share in Value by Application in 2022
Figure 44. Latin America Oncology Injection Drug Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Oncology Injection Drug Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Oncology Injection Drug Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Oncology Injection Drug Manufacturing Cost Structure
Figure 49. Oncology Injection Drug Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries